Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Scanlon

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Cancer Gene Therapy|March 1, 1995
Cancer gene therapy clinical trialsR E Sobol, K J Scanlon
Chemotherapy|January 1, 1989
Drug selectivity and membrane transport properties of normal human lymphocytesM Kashani-Sabet, K J Scanlon
Cancer Gene Therapy|December 19, 2013
The promised landR E Sobol, K J Scanlon
Cancer Research|July 1, 1986
Properties of amino acid transport systems in K562 cells sensitive and resistant to cis-diamminedichloroplatinum(II)S Shionoya, Y Lu, K J Scanlon
In Vivo (Athens, Greece)|January 1, 1991
Dihydrofolate reductase gene expression characterized by the PCR assay in human leukemia cellsH Miyachi, H Han, K J Scanlon
Methods in Molecular Medicine|March 11, 2011
Anti-c-erb1B2 Ribozyme for Gene Therapy of Breast CancerT Suzuki, M Bessho, K J Scanlon
The Journal of Biological Chemistry|April 5, 1988
Biochemical and molecular properties of cisplatin-resistant A2780 cells grown in folinic acidY Lu, J Han, K J Scanlon
Cancer Treatment Reviews|December 1, 1990
Cyclosporin A suppresses cisplatin-induced oncogene expression in human cancer cellsK J Scanlon, W Z Wang, H Han
The Journal of Biological Chemistry|July 5, 1990
Cyclosporin A suppresses cisplatin-induced c-fos gene expression in ovarian carcinoma cellsM Kashani-Sabet, W Wang, K J Scanlon
Proceedings of the National Academy of Sciences of the United States of America|November 8, 1994
Ribozyme-mediated reversal of the multidrug-resistant phenotypeK J Scanlon, H Ishida, M Kashani-Sabet
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Cancer Gene Therapy|March 1, 1995
Cancer gene therapy clinical trialsR E Sobol, K J Scanlon
Chemotherapy|January 1, 1989
Drug selectivity and membrane transport properties of normal human lymphocytesM Kashani-Sabet, K J Scanlon
Cancer Gene Therapy|December 19, 2013
The promised landR E Sobol, K J Scanlon
Cancer Research|July 1, 1986
Properties of amino acid transport systems in K562 cells sensitive and resistant to cis-diamminedichloroplatinum(II)S Shionoya, Y Lu, K J Scanlon
In Vivo (Athens, Greece)|January 1, 1991
Dihydrofolate reductase gene expression characterized by the PCR assay in human leukemia cellsH Miyachi, H Han, K J Scanlon
Methods in Molecular Medicine|March 11, 2011
Anti-c-erb1B2 Ribozyme for Gene Therapy of Breast CancerT Suzuki, M Bessho, K J Scanlon
The Journal of Biological Chemistry|April 5, 1988
Biochemical and molecular properties of cisplatin-resistant A2780 cells grown in folinic acidY Lu, J Han, K J Scanlon
Cancer Treatment Reviews|December 1, 1990
Cyclosporin A suppresses cisplatin-induced oncogene expression in human cancer cellsK J Scanlon, W Z Wang, H Han
The Journal of Biological Chemistry|July 5, 1990
Cyclosporin A suppresses cisplatin-induced c-fos gene expression in ovarian carcinoma cellsM Kashani-Sabet, W Wang, K J Scanlon
Proceedings of the National Academy of Sciences of the United States of America|November 8, 1994
Ribozyme-mediated reversal of the multidrug-resistant phenotypeK J Scanlon, H Ishida, M Kashani-Sabet
Pageof 9